Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Pharmacology and Therapeutics"
DOI: 10.1002/cpt.2646
Abstract: The coronavirus disease 2019 (COVID‐19) antiviral nirmatrelvir/ritonavir (Paxlovid) has been granted authorization or approval in several countries for the treatment of patients with mild to moderate COVID‐19 at high risk of progression to severe disease… read more here.
Keywords: nirmatrelvir ritonavir; risk; ritonavir; drug ... See more keywords
Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Cancer"
DOI: 10.1016/j.ejca.2020.05.027
Abstract: Highlights • We summarised immunosuppressing anticancer drugs which could worsen COVID 19 infections.• Other drugs were studied for drug-drug interactions with antiviral medicines.• A ready-to-use table synthesised these interactions between antiviral and anticancer drugs. read more here.
Keywords: drugs covid; anticancer drugs; antiviral treatments; covid antiviral ... See more keywords
Disproportionate distribution of coronavirus disease 2019 (COVID-19) antiviral pills: Vaccine inequity replay?
Sign Up to like & getrecommendations! Published in 2021 at "Infection Control and Hospital Epidemiology"
DOI: 10.1017/ice.2021.532
Abstract: To the Editor—The rapid development of the coronavirus disease 2019 (COVID-19) vaccine was only possible due to massive international collaboration in the research and development sector. However, the disproportionate distribution of vaccines led to COVID-19… read more here.
Keywords: covid; disease; distribution; covid antiviral ... See more keywords
Targeting SARS-CoV-2 Proteases for COVID-19 Antiviral Development
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Chemistry"
DOI: 10.3389/fchem.2021.819165
Abstract: The emergence of severe acute respiratory syndrome (SARS-CoV-2) in 2019 marked the third occurrence of a highly pathogenic coronavirus in the human population since 2003. As the death toll surpasses 5 million globally and economic… read more here.
Keywords: antiviral development; proteases covid; targeting sars; sars cov ... See more keywords